Investigating the role of TGF-β and BDNF in cancer-related depression: a primary cross-sectional study
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08542-y ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Jingjing Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Transforming Growth Factor beta, Depression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: the National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Cancer-related depression is a well-documented condition that significantly impacts long-term quality of life. Brain-derived neurotrophic factor (BDNF), a neurotrophin essential for neurogenesis and neuronal plasticity, has been implicated in various neuropsychological disorders including depression associated with cancer. Cytokines, on the other hand, play a crucial role in regulating depression, potentially by influencing BDNF expression. Transforming growth factor-β (TGF-β), a key immune regulator within the tumor microenvironment, has been found to elevate BDNF levels, establishing a link between peripheral immune responses and depression. The study aims to investigate the correlation of TGF-β and BDNF in cancer-related depression. METHODS: This study involved a cohort of 153 gynecological patients, including 61 patients with gynecological cancer and 92 patients without cancer. Depression levels were assessed using the subscale of Hospital Anxiety and Depression Scale (HADS-D), and TGF-β and BDNF plasma levels were measured using enzyme-linked immunosorbent assay (ELISA). RESULTS: The study revealed elevated plasma TGF-β levels in patients with cancer (32.24 ± 22.93 ng/ml) compared to those without cancer (25.24 ± 19.72 ng/ml) (P = 0.046). Additionally, reduced levels of BDNF were observed in patients presenting depression symptoms (44.96 ± 41.06 pg/ml) compared to those without depression (133.5 ± 176.7 pg/ml) (P = 0.036). Importantly, a significant correlation between TGF-β and BDNF was found in patients without cancer but with depression (correlation coefficient = 0.893, **P < 0.01). Interestingly, cancer appeared to influence the association between TGF-β and BDNF in patients with depression, as evidenced by a significant difference in the correlation of TGF-β and BDNF between cancer and non-cancer groups (P = 0.041). CONCLUSIONS: These findings underscore the active involvement of TGF-β and BDNF crosstalk in the context of cancer-related depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing, Southern Medical University, Guangzhou, China.
- Health College, Zhejiang Industry Polytechnic College, Shaoxing, China.
- Department of Biology, University of Copenhagen, Copenhagen, Denmark.
- Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- School of Nursing, Southern Medical University, Guangzhou, China. zhanglili_gz@126.com.
- School of Nursing, Southern Medical University, Guangzhou, China. liuyawei_smu@126.com.
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Lin, J., Xiao, L., Nie, X., Wang, Z., Luo, Y., Zhang, L., & Liu, Y. (2024). Investigating the role of TGF-β and BDNF in cancer-related depression: a primary cross-sectional study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08542-y
Vancouver
Lin J, Xiao L, Nie X, Wang Z, Luo Y, Zhang L, et al. Investigating the role of TGF-β and BDNF in cancer-related depression: a primary cross-sectional study. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08542-y
BibTeX
@article{Lin2024,
author = {Lin, Jingjing and Xiao, Lin and Nie, Xinchen and Wang, Zhijian and Luo, Yuanyuan and Zhang, Lili and Liu, Yawei},
title = {Investigating the role of TGF-β and BDNF in cancer-related depression: a primary cross-sectional study},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08542-y}
}
EUVIMED